Stocks Hitting 52-Week Lows

By: via Benzinga
Ohr Pharmaceutical, Inc (NASDAQ: OHRP) shares reached a new 52-week low of $3.04 on failure to reach goal in OHR-102 Phase II study. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.